Table 1.

Summary of Consensus Statements and Sample Quality Indicators to Prevent AKI and Its Consequences in the Community

Consensus Statements	Sample Quality Indicators
1A: Health care professionals and systems should be able to identify patients and populations in community settings who are at high risk for AKI. 1B: We suggest that a minimum set of susceptibilities and exposures be considered for AKI risk stratification.	Presence of health record or system to identify patients with risk factors, including prior episodes of AKI Presence of an alert system to communicate high-risk status to clinicians and patients The proportion of high-risk patients who are monitored for AKI
2A: We suggest patients at risk for AKI have a KHA periodically, and at least every 12 months, to define and modify their AKI risk profile. 2B: We suggest that high-risk patients have another KHA at least 30 days before and again 2–3 days after a planned exposure that carries AKI risk. The KHA should be tailored to the clinical context and clinician judgment. 2C: The KHA should occur as soon as an unplanned exposure is recognized that carries AKI risk.	Presence of an alert or communication system to inform health care providers that an update of KHA is required The proportion of patients at high risk for AKI with a serum creatinine measurement in the past 12 months The proportion of patients with diabetes who have a serum creatinine measurement ≤72 hours after a coronary angiogram The proportion of patients with CKD who have a blood pressure check to assess for hypotension (ie, intravascular volume depletion or septic shock) at the time of antibiotic prescription
3A: The KHR should precede an acute exposure that carries AKI risk or occur as soon as an unplanned acute exposure is recognized. 3B: We suggest high-risk patients and their caregivers receive formal education on their baseline kidney function and exposures for AKI. 3C: We suggest coordination between all stakeholders to address socioeconomic-cultural and environmental factors that increase the risk of AKI.	Presence of programs to educate high-risk patients about AKI exposures Presence of care pathways for high-risk exposures that can mitigate the risk of AKI (eg, hydration practices prior to iodinated contrast) The proportion of high-risk patients who can provide their serum creatinine or estimated glomerular filtration rate prior to a coronary angiogram The proportion of patients who develop AKI after a high-risk exposure

AKI = acute kidney injury; CKD = chronic kidney disease; KHA = Kidney Health Assessment; KHR = Kidney Health Response.